Defibrillators Market Share

  • Report ID: 4284
  • Published Date: Aug 14, 2025
  • Report Format: PDF, PPT

Defibrillators Market - Regional Analysis

North America Market Insights

North America is estimated to maintain its dominance over the global market with a share of 42.3% throughout the discussed timeframe. The well-established healthcare system, high prevalence of cardiovascular disease, and strong government support for emergency response systems are the primary drivers behind the region's leading augmentation in this sector. The continuous demographic expansion on account of the enlarging geriatric, obese, and diabetic populations is also fueling demand in this field. Testifying to the same, the 2022 American Heart Association Heart and Stroke Statistics revealed that more than 356 thousand OHCA occur every year in the U.S., with 90.0% of them being fatal.

The U.S. stands as the leader of the regional market, which is backed by a robust healthcare infrastructure and high CVD prevalence. According to the Centers for Disease Control and Prevention (CDC), atrial fibrillation alone contributes to approximately 454,000 hospitalizations and 158,000 deaths every year, fueling demand in this sector. Besides, the continuous capital influx from governing bodies also indicates the lucrative inflow of cash in this sector. As evidence, in March 2025, the Ventura Fire Department launched a new fleet of cardiac monitor defibrillators to empower the emergency medical care community of the country. This led to the purchase of 20 new LIFEPAK 35 devices against an investment of USD 1.28 million.

The improvement in access and cardiac emergency response is the key growth driver in the Canada market. As CA has become a national health concern for the country, bystanders are increasingly adopting the use of CPR and AED promptly to enhance survival rates. Besides, the federal government, in partnership with institutional and commercial organizations, is heavily investing to propel the availability and innovation in this sector. As evidence, in May 2025, the University of Toronto, in collaboration with Daysix, developed a new online tool, PADmap, to improve survival rates in OHCA cases by improving the placement of public access defibrillators (PADs).

APAC Market Insights

Asia Pacific is predicted to become the fastest-growing region in the global defibrillators market by the end of 2035. Robust expansion in the CVD demography, healthcare infrastructure, and access to life-saving technologies is remarkably evolving the landscape into a lucrative scope of investment for both international and local pioneers. This epidemiology can be evidenced by a 2024 journal of Heart, Lung and Circulation, which revealed that yearly financial losses due to SCA alone in Australia accounted for more than AUD$2 billion. It also mentioned that this amount was almost equal to the productivity losses from all cancers combined. Moreover, the acceleration in urbanization, emergency response timeline, and medical tourism growth is consolidating a significant position for the region in this sector.

China is establishing a strong consumer base for the defibrillators market with regional dominance, owing to its large population and increasing CVD mortality. As per the 2022 NLM article, more than 230 million people in the country were affected by these ailments, where approximately 55 thousand CA incidences occurred annually. This highlights the growing need for timely medical attention, which has become a necessity for the country's healthcare system. Besides, the gaps in emergency response and defibrillator access are attracting both MedTech leaders and public investors to engage more resources in this field. As evidence, the government of China continues to invest in public health infrastructure and emergency preparedness, including broader AED deployment and training programs.

India is emerging as a key growth engine for the Asia Pacific defibrillators market on account of the increasing awareness of cardiac emergencies and modernizing healthcare infrastructure. Following this momentum, in March 2024, Stryker unveiled its next-generation LIFEPAK CR2 AED along with an Evacuation Chair at the Criticare National Conference in Kolkata. This was aimed at capitalizing on the enhancement of the nation's cardiac care and emergency response capabilities in both public and private settings. Moreover, as India continues to invest in emergency medical services and public access programs, this sector is expected to grow steadily.

Country-wise Incidence Rates of Cardiac Arrests

Country

CA Type

Incidence Rate

Australia

Out-of-Hospital

107.9 per 100,000 person-years

South Korea

Out-of-Hospital

95.1 cases per 100,000 population

Malaysia

In-Hospital

19.8 per 1,000 hospital admissions

Source: NLM and PHWR

Europe Market Insights

In Europe, innovation and epidemiological expansion are expected to maintain the position of the second-largest shareholder in the global defibrillators market between 2026 and 2035. This can be exemplified by the collaboration of Hato Hone St John with ViVest in June 2024 to collectively develop the first-ever Hato Hone St John-branded AED. The device was designed to deliver a shock in as little as seven seconds, making it a user-friendly device that provides clear visual and verbal instructions. Such discoveries are enhancing the accessibility of this sector to individuals without prior AED training, where strong government initiatives are actively promoting AED availability and bystander intervention.

The UK attained a prominent rank in revenue generation from the Europe defibrillators market, followed by the massive government-led allocations and deployment goals. For instance, in July 2023, more than 20 thousand devices were delivered to nearly 18 thousand schools since January as part of a £19 million national rollout strategy. On the other hand, the country's emergency services performing resuscitation attempts on approximately 34 thousand people each year is also fueling demand in this sector. This also underscores the urgent need for the reinforcement of early recognition, CPR, and timely intervention measures that are crucial to improving survival rates.

Germany is a key landscape in the Europe defibrillators market, consolidated by strong healthcare system and government-led initiatives, improving cardiac arrest survival rates. The government of the country has been proactive in promoting wide accessibility and availability, which also deepens the sector's penetration. Additionally, the collaborations between nonprofit organizations and governing bodies are accelerating the pace of acceptance and adoption in this category. Such initiatives also propel innovations that enhance the functionality of AEDs in emergencies.

Country-wise Annual Count of CA Events

Country

Event Type

Annual Count (Thousand)

Spain

Incidence

52.3

Italy

Incidence

60.0 (OHCAs)

Switzerland

Death

8.0

Source: CAPAC, NLM, and USZ

Defibrillators Market Share

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of the defibrillators market was over USD 10.8 billion.

The market size for the defibrillators market is projected to reach USD 23.1 billion by the end of 2035, expanding at a CAGR of 9% during the forecast period, i.e., between 2026-2035.

The major players in the market are Medtronic, Boston Scientific, Abbott Laboratories, Philips, ZOLL Medical, Biotronik, and others.

In terms of product type, the implantable cardioverter defibrillators (ICDs) segment is anticipated to garner the largest market share of 54.6% by 2035 and display lucrative growth opportunities during 2026-2035.

The market in North America is projected to hold the largest market share of 42.3% by the end of 2035 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos